BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15196631)

  • 1. Incorporation of ovalbumin into ISCOMs and related colloidal particles prepared by the lipid film hydration method.
    Demana PH; Davies NM; Berger B; Rades T
    Int J Pharm; 2004 Jul; 278(2):263-74. PubMed ID: 15196631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quil A-lipid powder formulations releasing ISCOMs and related colloidal structures upon hydration.
    Demana PH; Davies NM; Hook S; Rades T
    J Control Release; 2005 Mar; 103(1):45-59. PubMed ID: 15710499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of pseudo-ternary diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by lipid-film hydration and dialysis.
    Demana PH; Davies NM; Berger B; Vosgerau U; Rades T
    J Pharm Pharmacol; 2004 May; 56(5):573-80. PubMed ID: 15142333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for the incorporation of ovalbumin into immune stimulating complexes prepared by the hydration method.
    Könnings S; Copland MJ; Davies NM; Rades T
    Int J Pharm; 2002 Jul; 241(2):385-9. PubMed ID: 12100866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-stimulating complexes prepared by ethanol injection.
    Lendemans DG; Myschik J; Hook S; Rades T
    J Pharm Pharmacol; 2005 Jun; 57(6):729-33. PubMed ID: 15969927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of cationic derivatives of Quil A and the preparation of cationic immune-stimulating complexes (ISCOMs).
    Pham HL; Ross BP; McGeary RP; Shaw PN; Davies NM
    Int J Pharm; 2009 Jul; 376(1-2):123-33. PubMed ID: 19375488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudo-ternary phase diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by the lipid-film hydration method.
    Demana PH; Davies NM; Vosgerau U; Rades T
    Int J Pharm; 2004 Feb; 270(1-2):229-39. PubMed ID: 14726138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of immuno-stimulating complexes (ISCOMs) by ether injection.
    Pham HL; Shaw PN; Davies NM
    Int J Pharm; 2006 Mar; 310(1-2):196-202. PubMed ID: 16413713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the preparation, microscopic investigation and application of ISCOMs.
    Myschik J; Lendemans DG; McBurney WT; Demana PH; Hook S; Rades T
    Micron; 2006; 37(8):724-34. PubMed ID: 16750912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel method for preparing immune stimulating complexes (ISCOMs) by hydration of freeze-dried lipid matrix.
    Liang M; Toth I; Davies NM
    Eur J Pharm Biopharm; 2008 Mar; 68(3):840-5. PubMed ID: 18182279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cage-like complexes formed by DOTAP, Quil-A and cholesterol.
    Lendemans DG; Egert AM; Hook S; Rades T
    Int J Pharm; 2007 Mar; 332(1-2):192-5. PubMed ID: 17049770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydration of lipid films with an aqueous solution of Quil A: a simple method for the preparation of immune-stimulating complexes.
    Copland MJ; Rades T; Davies NM
    Int J Pharm; 2000 Mar; 196(2):135-9. PubMed ID: 10699704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the dilution behaviour of immuno-stimulating complexes (ISCOMs).
    Lendemans DG; Egert AM; Myschik J; Hook S; Rades T
    Pharmazie; 2006 Aug; 61(8):689-95. PubMed ID: 16964712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs).
    Pham HL; Ross BP; McGeary RP; Shaw PN; Hewavitharana AK; Davies NM
    Curr Drug Deliv; 2006 Oct; 3(4):389-97. PubMed ID: 17076641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic cage-like complexes formed by DC-cholesterol, Quil-A, and phospholipid.
    Lendemans DG; Myschik J; Hook S; Rades T
    J Pharm Sci; 2005 Aug; 94(8):1794-807. PubMed ID: 15986471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo investigation of twin-screw extruded lipid implants for vaccine delivery.
    Even MP; Young K; Winter G; Hook S; Engert J
    Eur J Pharm Biopharm; 2014 Jul; 87(2):338-46. PubMed ID: 24607791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mannosylated saponins based on oleanolic and glycyrrhizic acids. Towards synthetic colloidal antigen delivery systems.
    Daines AM; Greatrex BW; Hayman CM; Hook SM; McBurney WT; Rades T; Rendle PM; Sims IM
    Bioorg Med Chem; 2009 Jul; 17(14):5207-18. PubMed ID: 19502067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the structure of immune-stimulating saponin-lipid complexes (iscoms).
    Kersten GF; Spiekstra A; Beuvery EC; Crommelin DJ
    Biochim Biophys Acta; 1991 Feb; 1062(2):165-71. PubMed ID: 2004105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
    Robson NC; Donachie AM; Mowat AM
    Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution study using Egg Protein ELISA kit after administration of FITC-labeled ovalbumin solution and its double liposomes in the in situ loop method, and its implication in oral immunization.
    Masutomi T; Onishi H; Takahashi Y; Machida Y
    Curr Drug Deliv; 2010 Dec; 7(5):447-52. PubMed ID: 20950263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.